Fundraising Fox

Neely Mozaffarian

Chief Medical Officer at Ouro Medicines

Seattle, Washington, United States

Find your path to Neely

103 people in our graph share verified history with Neely — schools, employers, funds. One of them is your warm intro.

Laura QuockunlockedNeely: together at AbbVie (2013)
×8Neely: together at AbbVie
Neely: together at Ichnos Sciences
Neely: together at Fate Therapeutics

Chief Medical Officer at Ouro Medicines

Intro paths

→

In turn, Neely can intro founders to Ouro Medicines's investors below.

Ouro Medicines's investors · 4

Monograph Capital PartnersLondon · since 2025New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2025Norwest Venture PartnersMenlo Park · $10M – $30M checks · since 2025TPGSan Francisco

Co-founders at Ouro Medicines

J
JaideepFounding Chief Executive Officer

Experience

  1. Ouro MedicinesCMO, Head of Developmentcurrent2024 — present
  2. Rheumatology Frontiers in MedicineJournal Review Editorcurrent2022 — present
  3. Fate Therapeutics Inc.Board of Directors, Independent Member2024 — 2025
  4. AtomwiseCMO, Head of Development2023 — 2024United States
  5. GentiBioCMO, Head of Development2022 — 2023Cambridge, Massachusetts, United States
  6. The Janssen Pharmaceutical Companies of Johnson & JohnsonVice President, Autoantibody Pathway Area Leader and Cambridge Site Head2021 — 2022
  7. Ichnos SciencesSenior VP, Head of Clinical Development2019 — 2021Greater New York City Area
  8. Gilead SciencesExecutive Director, Group Leader Rheumatology/Autoimmunity Global Clinical Development2016 — 2019Foster City, CA
  9. Eli Lilly and CompanySenior Medical Director, Head, Global Early Immunology Clinical Development2013 — 2016Lilly Biotechnology Center
  10. AbbVie, Inc. (formerly Abbott Laboratories)Medical Director, Global Clinical Development, HUMIRA and Early Immunology2009 — 2013AbbVie, Inc. (formerly Abbott Laboratories)
  11. Bristol-Myers SquibbMedical Liaison2008 — 2009
  12. University of WashingtonPhysician, Rheumatology / Internal Medicine2001 — 2008Seattle, WA

Skills & more

Board of DirectorsTeam BuildingStrategic LeadershipBoard Governance2Leadership1Orphan Drugs1Medical EducationStrategic ThinkingBusiness StrategyImmunology43Rheumatology35Clinical Development32
+8 moreInternal MedicinePharmaceutical IndustryMedicineClinical TrialsDrug DevelopmentGCPMedical AffairsInflammation

From Neely's professional profile.

Frequently asked questions

Who is Neely Mozaffarian?
Chief Medical Officer at Ouro Medicines
Where does Neely Mozaffarian work?
Neely Mozaffarian is Chief Medical Officer at Ouro Medicines.
Where did Neely Mozaffarian go to school?
Neely Mozaffarian studied at Albert Einstein College of Medicine (MD, PhD, Medicine, Microbiology and Immunology); University of Washington (Fellowship, Rheumatology Residency Program); University of Washington (Internship/Residency, Internal Medicine Residency Program).

Same school

Also attended Albert Einstein College of Medicine21

Perry NisenExecutive Advisor, Private Equity at Sofinnova VenturesRichard StumacherClinical Advisor at Seae VenturesScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesSam GoldbergerManaging Partner at Ambit Health VenturesGur RoshwalbPartner at aMoonDr. Yair SapersteinFounder / CEO at Avo

+ 15 more

Also attended University of Washington608

Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesJoe HorsmanInvestor at Madrona Venture Group

+ 602 more

Shared employers

Also worked at Ouro Medicines4

Tim FunnellPartner at Monograph Capital PartnersJaideep DudaniPrincipal at Monograph Capital PartnersCharlie ZhouInvestment Manager at Monograph Capital PartnersKristina NebelUS Operations Manager at Monograph Capital Partners

Also worked at Gilead Sciences55

Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionKate ButlerInvestor at Syncona

+ 49 more

Also worked at Eli Lilly and Company189

David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital

+ 183 more

Also worked at AbbVie, Inc. (formerly Abbott Laboratories)67

Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures

+ 61 more